Attention should be paid to the management of side effects, contraindications, and special medication situations for Mictonorm hydrochloride tablets. It is necessary to strictly follow medical advice to ensure medication safety. The following provides a detailed explanation from three aspects: coping with side effects, contraindications, and special precautions.

1. Side effect management

(1) Common anticholinergic reactions include dry mouth, constipation, and blurred vision. It is recommended to administer the medication in divided doses and maintain sufficient water intake. Elderly patients should be more alert to worsening symptoms.

(2) Central nervous system impact

Sleepiness and dizziness may occur. During medication, driving or operating precision instruments should be avoided, especially when combined with sedatives, and monitoring should be strengthened.

(3) Cardiovascular system monitoring

Patients with tachycardia or palpitations should seek medical attention promptly. For those with a history of heart disease, it is recommended to reduce the initial dose by half and undergo regular electrocardiogram examinations.

2 taboo groups

(1) Patients with angle closure glaucoma are strictly prohibited from using the medication, as it may induce acute attacks and irreversible visual impairment.

(2) Prostate hyperplasia patients

Urinary retention may occur in severe cases, which requires urodynamic evaluation and emergency catheterization equipment.

(3) Patients with myasthenia gravis

May exacerbate muscle weakness symptoms, requiring a neurologist to evaluate the risk benefit ratio before medication.

3 Special precautions

(1) Patients with renal insufficiency need to adjust the dosage according to creatinine clearance rate, and those with severe renal impairment should avoid drug accumulation.

(2) Individuals with abnormal liver function

Patients with moderate to severe liver injury should reduce their use and regularly monitor their transaminase levels.

(3) Elderly patients

Suggest reducing the initial dose by 25% -50% and strengthening monitoring of anticholinergic side effects.

(4) Drug interactions

Avoid co administration with strong CYP3A4 inhibitors, adjust the dosage and monitor for adverse reactions when necessary.